Navigation Links
RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
Date:5/8/2012

LEESBURG, Va., May 8, 2012 /PRNewswire/ -- RxAlly, the first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today the expansion of its national network with the addition of nine Independent Pharmacy Organizations and ten Regional Chains. These organizations collectively represent more than 2,000 pharmacies with a footprint spanning from the Northeast through Appalachia and the Midwest out to the Western United States. In just over three months since the company launched, RxAlly has grown its membership by more than 2,000 pharmacies. 

The newest Independent Pharmacy Organization members of RxAlly are:

  • Association of Northwest Pharmacies (WA)
  • CBI Pharmacy Network (OK)
  • Keystone Pharmacy Purchasing Alliance (PA)
  • Northeast Pharmacy Service Corporation (MA)
  • Partners in Pharmacy Cooperative (WI)
  • Pharmacy Franchisees and Owners Association (MO)
  • Rochester Drug Cooperative (NY)
  • RxPlus Pharmacies (CO)
  • Value Drug Company (PA)

The newest Regional Chain members of RxAlly are:

  • Doc's Drugs (IL)
  • Drug Emporium (WV)
  • Fruth Pharmacy (WV)
  • Hi-School Pharmacy (WA)
  • Hometown Pharmacy (WI)
  • Lifechek Drug (TX)
  • Osborn Drugs (OK)
  • Reasor's Pharmacy (OK)
  • Sav-Mor Drug Stores (MI)
  • U-Save-It Pharmacy (GA)

"The addition of these esteemed independent pharmacy organizations and regional chains to our network makes us that much stronger as a national alliance," said Bruce Roberts, R.Ph, CEO of RxAlly. "The continued expansion of our network is testament to the importance of advancing the role of local pharmacists and improving our health care system." 

RxAlly is a performance network of aligned pharmacies united to help patients achieve better health through personalized pharmacist care, while reducing costs. The company was developed to provide a new solution to the critical issues of providing additional access to care and ensuring effective health care spending at a time when prescription medicine misuse is associated with $290 billion in annual costs.

For more information, please visit us at www.RxAlly.com, on Facebook or Twitter.

For media inquiries, please contact: 5W Public Relations.

About RxAlly:

With more than 22,000 member pharmacies nationwide, RxAlly has brought together the largest national network of pharmacies to improve health and lower costs. The RxAlly Performance Network of community pharmacies aims to improve health through personalized pharmacist care, clinical research and evidence-based clinical practices, and an interoperable technology platform. By advancing the role of pharmacists, RxAlly is facilitating new solutions as it leads an innovative approach to health care that aligns the interests of patients, pharmacists and payers. For more information on RxAlly, please visit www.RxAlly.com.


'/>"/>
SOURCE RxAlly
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
3. Cellectar Expands Clinical Management Team
4. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
7. PAREXEL Expands Global Clinical Pharmacology Capabilities
8. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
11. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):